跳至主要内容
临床试验/EUCTR2010-021786-78-AT
EUCTR2010-021786-78-AT进行中(未招募)1 期

Treatment of chronic lymphocytic leukemia with the use of an antiviral compound - a proof of principle study

Medizinische Universität Wien0 个研究点开始时间: 2010年9月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • CLL confirmed by immunophenotyping and a relative preponderance of leukemic cells of >70%
  • CLL patients with expression of immunoglobuline heavy chains (IGHV) 1-69 or 3-21
  • Seropositive for CMV-specific IgG-antibodies
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 5
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • CLL patients who received treatment for their disease, i.v. immunoglobulines, or anti-CMV treatment within 3 months prior to enrollment.

研究者

相似试验